Arterio-venous disorders influenced centrally with Mydocalm.
D001158:Arteries; D006801:Humans; D007668:Kidney / Q000098:blood supply; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D010880:Piperidines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D011427:Propiophenones / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D012039:Regional Blood Flow; D014652:Vascular Diseases / Q000188:drug therapy* / Q000503:physiopathology; D014680:Veins
D009125:Muscle Relaxants, Central; D010880:Piperidines; D011427:Propiophenones